555 related articles for article (PubMed ID: 31644429)
1. Mesenchymal stem cell senescence alleviates their intrinsic and seno-suppressive paracrine properties contributing to osteoarthritis development.
Malaise O; Tachikart Y; Constantinides M; Mumme M; Ferreira-Lopez R; Noack S; Krettek C; Noël D; Wang J; Jorgensen C; Brondello JM
Aging (Albany NY); 2019 Oct; 11(20):9128-9146. PubMed ID: 31644429
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 induces chondrocyte senescence and cartilage damage via endothelin receptor type B in a post-traumatic osteoarthritis mouse model.
Au M; Liu Z; Rong L; Zheng Y; Wen C
Osteoarthritis Cartilage; 2020 Dec; 28(12):1559-1571. PubMed ID: 32858189
[TBL] [Abstract][Full Text] [Related]
3. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice.
Khan M; Mohsin S; Khan SN; Riazuddin S
J Cell Mol Med; 2011 Jul; 15(7):1515-27. PubMed ID: 20041970
[TBL] [Abstract][Full Text] [Related]
4. Implication of Cellular Senescence in Osteoarthritis: A Study on Equine Synovial Fluid Mesenchymal Stromal Cells.
Teti G; Mazzotti E; Gatta V; Chiarini F; Alfieri ML; Falconi M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834521
[TBL] [Abstract][Full Text] [Related]
5. Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs.
Wang N; He Y; Liu S; Makarcyzk MJ; Lei G; Chang A; Alexander PG; Hao T; Padget AM; de Pedro N; Menelaos T; Lin H
Sci China Life Sci; 2022 Feb; 65(2):309-327. PubMed ID: 34109475
[TBL] [Abstract][Full Text] [Related]
6. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.
Jeon OH; Kim C; Laberge RM; Demaria M; Rathod S; Vasserot AP; Chung JW; Kim DH; Poon Y; David N; Baker DJ; van Deursen JM; Campisi J; Elisseeff JH
Nat Med; 2017 Jun; 23(6):775-781. PubMed ID: 28436958
[TBL] [Abstract][Full Text] [Related]
7. Controlled induction and targeted elimination of p16
Sessions GA; Copp ME; Liu JY; Sinkler MA; D'Costa S; Diekman BO
FASEB J; 2019 Nov; 33(11):12364-12373. PubMed ID: 31408372
[TBL] [Abstract][Full Text] [Related]
8. Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis.
Varela-Eirín M; Varela-Vázquez A; Guitián-Caamaño A; Paíno CL; Mato V; Largo R; Aasen T; Tabernero A; Fonseca E; Kandouz M; Caeiro JR; Blanco A; Mayán MD
Cell Death Dis; 2018 Dec; 9(12):1166. PubMed ID: 30518918
[TBL] [Abstract][Full Text] [Related]
9. Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients.
Miura Y; Endo K; Komori K; Sekiya I
Stem Cell Res Ther; 2022 Jun; 13(1):222. PubMed ID: 35658936
[TBL] [Abstract][Full Text] [Related]
10. Paracrine effects of human adipose-derived mesenchymal stem cells in inflammatory stress-induced senescence features of osteoarthritic chondrocytes.
Platas J; Guillén MI; Pérez Del Caz MD; Gomar F; Castejón MA; Mirabet V; Alcaraz MJ
Aging (Albany NY); 2016 Aug; 8(8):1703-17. PubMed ID: 27490266
[TBL] [Abstract][Full Text] [Related]
11. p16
Chikenji TS; Saito Y; Konari N; Nakano M; Mizue Y; Otani M; Fujimiya M
EBioMedicine; 2019 Jun; 44():86-97. PubMed ID: 31129096
[TBL] [Abstract][Full Text] [Related]
12. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
Nadeau S; Cheng A; Colmegna I; Rodier F
Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
14. p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis.
Philipot D; Guérit D; Platano D; Chuchana P; Olivotto E; Espinoza F; Dorandeu A; Pers YM; Piette J; Borzi RM; Jorgensen C; Noel D; Brondello JM
Arthritis Res Ther; 2014 Feb; 16(1):R58. PubMed ID: 24572376
[TBL] [Abstract][Full Text] [Related]
15. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
16. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
Zhou HW; Lou SQ; Zhang K
Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16
Diekman BO; Sessions GA; Collins JA; Knecht AK; Strum SL; Mitin NK; Carlson CS; Loeser RF; Sharpless NE
Aging Cell; 2018 Aug; 17(4):e12771. PubMed ID: 29744983
[TBL] [Abstract][Full Text] [Related]
18. Murine mesenchymal cells that express elevated levels of the CDK inhibitor p16(Ink4a) in vivo are not necessarily senescent.
Frescas D; Hall BM; Strom E; Virtuoso LP; Gupta M; Gleiberman AS; Rydkina E; Balan V; Vujcic S; Chernova OB; Gudkov AV
Cell Cycle; 2017 Aug; 16(16):1526-1533. PubMed ID: 28650766
[TBL] [Abstract][Full Text] [Related]
19. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
20. Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic-kidney senescence and damage.
Kim SR; Jiang K; Chen X; Puranik AS; Zhu XY; Lerman A; Tchkonia T; Kirkland JL; Lerman LO
J Tissue Eng Regen Med; 2022 Jun; 16(6):550-558. PubMed ID: 35319825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
